Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
出版年份 2015 全文链接
标题
Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
作者
关键词
-
出版物
DRUG DELIVERY
Volume 23, Issue 4, Pages 1232-1241
出版商
Informa UK Limited
发表日期
2015-12-24
DOI
10.3109/10717544.2015.1124472
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials
- (2015) Meiyuan Xing et al. PLoS One
- Breast Cancer: Epidemiology and Etiology
- (2014) ZiQi Tao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
- (2014) Jing Yao et al. International Journal of Nanomedicine
- Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: Preparation, characterization and antitumor activity
- (2014) Ketan Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium
- (2014) Julie R. Palmer et al. JNCI-Journal of the National Cancer Institute
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid
- (2014) Chandraiah Godugu et al. PLoS One
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Gambogic acid inhibits angiogenesis through inhibiting PHD2–VHL–HIF-1α pathway
- (2013) Na Lu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Medium Chain Triglyceride (MCT) Rich, Paclitaxel Loaded Self Nanoemulsifying Preconcentrate (PSNP): A Safe and Efficacious Alternative to Taxol®
- (2013) Ketan Patel et al. Journal of Biomedical Nanotechnology
- Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells
- (2013) Ravi Doddapaneni et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Current trends in the use of liposomes for tumor targeting
- (2013) Pranali P Deshpande et al. Nanomedicine
- Challenges in Development of Targeted Liposomal Therapeutics
- (2012) Rupa R. Sawant et al. AAPS Journal
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
- (2012) Xu Wang et al. Anti-Cancer Agents in Medicinal Chemistry
- Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells
- (2012) Chenglin Li et al. Biochemistry and Cell Biology
- Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells
- (2012) Zheng-Yun Zou et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway
- (2011) Chenglin Li et al. BIOCHEMICAL PHARMACOLOGY
- Apoptosis: A Programme of Cell Death or Cell Disposal?
- (2011) W. O. Pereira et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells
- (2009) Hongyan Gu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The mitochondrial p53 pathway
- (2008) Angelina V. Vaseva et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
- (2008) Rajesh Naithani et al. CURRENT MEDICINAL CHEMISTRY
- Studies on the toxicity of gambogic acid in rats
- (2008) Qi Qi et al. JOURNAL OF ETHNOPHARMACOLOGY
- Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis
- (2008) Qi Qi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
- (2008) Dayong Zhai et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started